Results 221 to 230 of about 15,263 (254)

Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study. [PDF]

Acta Derm Venereol
Planella-Fontanillas N, Berna-Rico E, Figueras-Nart I, Spertino J, Dols Casanova L, Gatica Ortega ME, Expósito-Serrano V, Lasheras Pérez MA, Rodríguez Serna M, Mascaró JM, Melé-Ninot G, Mercader-García P, Navarro Triviño FJ, Tous Romero F, Elosua-González M, Magdaleno-Tapial J, Pérez Ferriols A, Montero-Vilchez T, Torné Gutiérrez JI, Gallardo F, Pesqué D, Pujol RM, Serra-Baldrich E, Giménez-Arnau AM.   +23 more
europepmc   +1 more source

Efficacy and Safety of Biologic Therapies for Uncontrolled Asthma: An Overview of Systematic Reviews. [PDF]

Pediatr Pulmonol
Faria RJ, Bazoni PS, Santos JBRD, Silva ETD, Silva MRRD.   +4 more
europepmc   +1 more source

Eosinophil subtypes in asthmatic patients treated with mepolizumab, omalizumab and dupilumab. [PDF]

ERJ Open Res
Cabrera López C, Sánchez Santos A, Lemes Castellano A, Cazorla Rivero S, González Dávila E, Celli B, Casanova Macario C.   +6 more
europepmc   +1 more source

Early Clinical Response Predicts Treatment Persistence in Advanced Therapy-naive Atopic Dermatitis. [PDF]

Acta Derm Venereol
Martínez-Simón JJ, Carrasco-Piernavieja L, Zhan Zhou E, Andreu-Barasoain MI, Sánchez-Gilo A, García-Zamora E, Collados-Arroyo V, Pérez-Encinas M, Vicente-Martín FJ, López-Estebaranz JL.   +9 more
europepmc   +1 more source

Evaluation of Selected Laboratory Parameters as Predictive Biomarkers of Clinical Response to Dupilumab Therapy in Patients with Atopic Dermatitis. [PDF]

Biomedicines
Waligóra-Dziwak K, Skrzypczak PJ, Jenerowicz D.   +2 more
europepmc   +1 more source

Comparative Neuropsychiatric Outcomes of JAK Inhibitors, Dupilumab, and Conventional Immunosuppressants in Atopic Dermatitis: A Real-World Cohort Study. [PDF]

Biomedicines
Wei CC, Li TJ, Chen HY, Huang JY, Lin TY, Wang JY, Liao WL, Wei JC.   +7 more
europepmc   +1 more source

Issue Information

JEADV Clinical Practice, Volume 5, Issue 3, Page 745-750, September 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dupilumab

Reactions Weekly
  +24 more sources